G Ribeiro

1.1k total citations
11 papers, 790 citations indexed

About

G Ribeiro is a scholar working on Cancer Research, Oncology and Genetics. According to data from OpenAlex, G Ribeiro has authored 11 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Oncology and 5 papers in Genetics. Recurrent topics in G Ribeiro's work include Breast Cancer Treatment Studies (7 papers), BRCA gene mutations in cancer (3 papers) and Cancer Treatment and Pharmacology (3 papers). G Ribeiro is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), BRCA gene mutations in cancer (3 papers) and Cancer Treatment and Pharmacology (3 papers). G Ribeiro collaborates with scholars based in United Kingdom, Peru and Brazil. G Ribeiro's co-authors include R Swindell, Daniel A. Jones, Michelle L. Jones, Matthew J. Harris, Soirindhri Banerjee, R. Swindell, M K Palmer, E. Wiltshaw, P. E. Hughesdon and Rafael Noronha Cavalcante and has published in prestigious journals such as British Journal of Cancer, British journal of surgery and Gynecologic Oncology.

In The Last Decade

G Ribeiro

10 papers receiving 754 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Ribeiro United Kingdom 10 384 356 285 241 194 11 790
Gabriel Farante Italy 10 506 1.3× 164 0.5× 236 0.8× 24 0.1× 332 1.7× 23 683
Jay R. Harris United States 12 913 2.4× 128 0.4× 455 1.6× 24 0.1× 639 3.3× 13 1.2k
Amy S. Langer United States 5 645 1.7× 211 0.6× 305 1.1× 40 0.2× 292 1.5× 8 859
Å Rimsten Sweden 14 201 0.5× 163 0.5× 352 1.2× 62 0.3× 164 0.8× 34 609
D Perrault Canada 11 162 0.4× 109 0.3× 382 1.3× 38 0.2× 107 0.6× 16 610
Gianluca Riboldi Italy 7 317 0.8× 55 0.2× 178 0.6× 21 0.1× 194 1.0× 10 449
Sabine Pöstlberger Austria 7 385 1.0× 106 0.3× 288 1.0× 26 0.1× 207 1.1× 10 502
Alan Stolier United States 18 674 1.8× 84 0.2× 126 0.4× 18 0.1× 440 2.3× 28 970
Piero Fregatti Italy 13 160 0.4× 59 0.2× 212 0.7× 105 0.4× 75 0.4× 54 495
G. Schubert-Fritschle Germany 16 185 0.5× 40 0.1× 485 1.7× 40 0.2× 99 0.5× 58 847

Countries citing papers authored by G Ribeiro

Since Specialization
Citations

This map shows the geographic impact of G Ribeiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Ribeiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Ribeiro more than expected).

Fields of papers citing papers by G Ribeiro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Ribeiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Ribeiro. The network helps show where G Ribeiro may publish in the future.

Co-authorship network of co-authors of G Ribeiro

This figure shows the co-authorship network connecting the top 25 collaborators of G Ribeiro. A scholar is included among the top collaborators of G Ribeiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Ribeiro. G Ribeiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Ribeiro, G, et al.. (2024). Desafios no Diagnóstico e Tratamento da Gravidez Ectópica: Uma Revisão Narrativa. Brazilian Journal of Implantology and Health Sciences. 6(8). 2038–2046.
2.
Ribeiro, G, et al.. (1993). The christie hospital breast conservation trial: An update at 8 years from inception. Clinical Oncology. 5(5). 278–283. 213 indexed citations
3.
Ribeiro, G & R Swindell. (1992). Adjuvant Tamoxifen for male breast cancer (MBC). British Journal of Cancer. 65(2). 252–254. 133 indexed citations
4.
Ribeiro, G & R Swindell. (1992). The Christie Hospital adjuvant tamoxifen trial.. PubMed. 121–5. 20 indexed citations
5.
Ribeiro, G, et al.. (1991). Use of an electron beam for post-mastectomy radiotherapy: 5-Year follow-up of 500 cases. Clinical Oncology. 3(6). 310–314. 11 indexed citations
6.
Ribeiro, G & R Swindell. (1988). The Christie hospital adjuvant tamoxifen trial – status at 10 years. British Journal of Cancer. 57(6). 601–603. 68 indexed citations
7.
Ribeiro, G, P. E. Hughesdon, & E. Wiltshaw. (1988). Squamous carcinoma arising in dermoid cysts and associated with hypercalcemia: A clinicopathologic study of six cases. Gynecologic Oncology. 29(2). 222–230. 38 indexed citations
8.
Ribeiro, G, Daniel A. Jones, & Michelle L. Jones. (1986). Carcinoma of the breast associated with pregnancy. British journal of surgery. 73(8). 607–609. 131 indexed citations
9.
Ribeiro, G & R. Swindell. (1985). The Christie Hospital Tamoxifen (Nolvadex) adjuvant trial for operable breast carcinoma - 7-yr results. European Journal of Cancer and Clinical Oncology. 21(8). 897–900. 48 indexed citations
10.
Ribeiro, G. (1985). Male breast carcinoma--a review of 301 cases from the Christie Hospital & Holt Radium Institute, Manchester. British Journal of Cancer. 51(1). 115–119. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026